Citation: H. Healy et al., Comparison of efficacy, cost, and comfort of three sites for subcutaneous injection of erythropoietin in hemodialysis patients, DIALYSIS T, 30(10), 2001, pp. 636
Citation: Hg. Thomson et al., The recurrent neurotrophic buttock ulcer in the meningomyelocele paraplegic: A sensate flap solution, PLAS R SURG, 108(5), 2001, pp. 1192-1196
Authors:
Healy, H
Reith, D
Morgan, C
Clague, A
Westhuyzen, J
Citation: H. Healy et al., Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?, ANN CLIN L, 30(3), 2000, pp. 295-304
Citation: J. Westhuyzen et H. Healy, Review: Biology and relevance of C-reactive protein in cardiovascular and renal disease, ANN CLIN L, 30(2), 2000, pp. 133-143
Authors:
Saltissi, D
Morgan, C
Westhuyzen, J
Healy, H
Citation: D. Saltissi et al., Comparison of low-molecular-weight heparin (enoxaparin sodium) and standard unfractionated heparin for haemodialysis anticoagulation, NEPH DIAL T, 14(11), 1999, pp. 2698-2703
Authors:
Healy, H
Booth, C
Clague, A
Westhuyzen, J
Citation: H. Healy et al., Hyperhomocysteinaemia in end-stage renal failure patients: Effect of low-dose supplementation with folic acid, NEPHROLOGY, 4(5-6), 1998, pp. 413-418
Citation: D. Healy et H. Healy, The clinical pharmacologic profile of reboxetine: does it involve the putative neurobiological substrates of wellbeing?, J AFFECT D, 51(3), 1998, pp. 313-322